Wird geladen...
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
<p>Abstract</p> <p>Recently Byrski et al. reported the first-ever breast cancer (BC) study, which specifically selected BRCA1-carriers for the neoadjuvant treatment and used monotherapy by cisplatin instead of conventional schemes. Although the TNM staging of the recruited patients...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
BMC
2009-04-01
|
Schriftenreihe: | Hereditary Cancer in Clinical Practice |
Online Zugang: | http://www.hccpjournal.com/content/7/1/8 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|